Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral develops devices for unmet medical needs. Sepsis occurs in 1.7M Americans/year causing 250K deaths, often caused by endotoxin. Our devices measure and remove endotoxin from the bloodstream. An FDA confirmatory trial is underway. Dialco, a Spectral sub, offers SAMI, a novel instrument for renal replacement, cleared by FDA. Dialco is seeking FDA approval for DIMI a unique home dialysis... see more

TSX:EDT - Post Discussion

Spectral Medical Inc > New Press Release - Spectral Medical Provides January Tigris Trial Update
View:
Comment by palinc2000 on Jan 30, 2024 10:14am
No more mention of results exceeding expectations...???
Comment by PezDalatoYou on Jan 30, 2024 11:08am
I noticed that as well. They sure like to keep everyone guessing. So, why is this info missing from this particular PR? 1. They forgot to put it in. 2. After so many PRs with it in, they felt it wasn't necessary anymore. 3. They aren't 'exceeding expectations' anymore and can't put it in and they don't want to share the revised state. 4. ? I'm guessing #2. I highly ...more  
Comment by ChesterLives on Jan 30, 2024 11:19am
I agree. 3 patients are not going to swing the trial. More likely that they didn't feel the need to say it for the 20th time.
Comment by gebremeskel on Jan 30, 2024 11:25am
Very funny! Just 5 patients to go.
Comment by palinc2000 on Jan 30, 2024 1:16pm
What doyou find funny?  
Comment by gebremeskel on Jan 30, 2024 1:37pm
Your takeaway from today's news release.
Comment by palinc2000 on Jan 30, 2024 2:10pm
I dont know what is funny in my pointing out a very significant omission in today s PR especially since ALL  trial up dates since at least November 2022 either mentioned encouraging results or results exceeding expectations so far!!!   I dont have any problens with the delays encountered so far ....ALL I am interested in are trial results and  I get very excited if they   ...more  
Comment by Spectracles on Jan 30, 2024 2:21pm
I think given that results were exeeding expectations at 82 patients I wouldn't worry about anything changing with the most recent 3. Just my two cents.
Comment by gebremeskel on Jan 30, 2024 3:11pm
If you have to explain a joke it spoils it! Nonetheless.... 20 days ago, in the January 10 news release Dr. Kellum stated: "Overall, we are rapidly advancing our Tigris trial and remain highly encouraged by the outlook, given the fact preliminary mortality data continues to exceed our expectations.” This news release also revealed that the 82nd patient had been enrolled. If  ...more  
Comment by Geery on Jan 30, 2024 3:32pm
Call or email the company to ask for clarification, if it is that important to you. No sense with the back and forth with neither of you knowing the correct answer.  Regards, Geery
Comment by Stocktree on Jan 30, 2024 8:17pm
I'm not saying the following will make a huge difference, but your logic does not seem correct there. Their 28 day data from 20 days ago also did not include the very last patients enrolled at the time. Any new compiled data (28 days) would not be about the latest group of patients enrolled, but about the latest group before that one, let's say the December group currently. The other ...more  
Comment by Revten on Jan 30, 2024 9:43pm
LOL! LOL! LOL! Stocktree are you kidding me! Trust me, you need to stop with the Nonsense because you completely do not understand the Trial or The PMX and what the object of The Trial Is!!!! It's not about the numbers, it's about the quality of the results.... Save yourself the embarrassment! Please! Mark this date down because months from now when the PMX is FDA Approved and ...more  
Comment by seniorcitizen11 on Jan 30, 2024 10:23pm
Stocktree: Don’t you ever get tired of being negative? You should take a break! I can only imagine how tiring it should for you to be to be so out of touch with the truth. 
Comment by Stocktree on Jan 31, 2024 11:29am
Just hit the ignore button and you will start feeling better again. I am not here for you, but for anyone who passes by and reads your silly gang of pumpers promotion materials. Out of touch with the truth? Spectral has financed Dialco and the development of its pumps. Once ready, Spectral then moved to have Dialco privatized, saying it would get 30% of the new i-Dialco revenues. Please let me ...more  
Comment by Spamme54321 on Jan 31, 2024 11:52am
Yes most of these pumpers like MercedesLadyBoy have been here for more than a decade pumping. They have been wrong for more than a decade on EDT but still keep pumping their drivel while at the same time trying to boast about how they bought at the bottom. LOL. I mean even Reddit's WallstreetBets does not have posters as highly regarded as these yahoos.
Comment by seniorcitizen11 on Jan 31, 2024 11:59am
Do I have this right Stocktree? You perform public service for free? You are not a shareholder? You do not beleive that EDT / PMX / EAA is a good investment and that management is performing. Your mission / reason for posting is to protect retail shareholders inclined to invest in Spectral from those who are heavily invested longs. Ignore button is not required, Your shtick is too obvious.
Comment by ChesterLives on Jan 31, 2024 3:35pm
Stocktree... you are outta gas. Time to leave.
Comment by palinc2000 on Feb 22, 2024 11:57am
Oversight ,,,,,yep you have great insight ,,,,lol
Comment by gebremeskel on Feb 22, 2024 12:11pm
As it turns out it was not an oversight. But it was not an occasion for hand-wringing either. They were just being more careful, which is all to the good. The poster with insight was Geery, who advised asking the company for clarification.
Comment by BlueJays9293 on Jan 30, 2024 1:19pm
It takes 28 days from enrolling a patient to get their mortality rate so the effects of these 4 patients won't factor into "exceeding expectations" until February so I don't see this as a big deal since the January 10 update still had that phrase.  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities